We showed that upregulation of ARHGEF15 in pancreatic cancer increased activation of the Rho-family proteins, especially RhoA, Cdc42 and Rac, resulting in enhanced motility of the pancreatic cancer cells. Here, RHOA is linked to familial pancreatic carcinoma.